Tag: Difficult-to-Treat Depression (DTD)
LivaNova and Verily Enroll First Patient in Study to Detect Depression Using Smartwatch
LivaNova, a market-leading medical technology and innovation company, and Verily, a subsidiary of Alphabet focused on life sciences and healthcare, announced that the first...
LivaNova’s VNS Therapy System Receives CE Mark for Difficult-to-Treat Depression
LivaNova, a leading medical technology and innovation company, based in London, announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark...